By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Auspex Pharmaceuticals 

1261 Liberty Way
Suite C
Vista  California  92081-8356  U.S.A.
Phone: 760-599-1800 Fax: 760-599-1801



Company News
Concert Pharmaceuticals, Inc. (CNCE) Receives $50 Million Payment From Auspex Pharmaceuticals (ASPX) 6/8/2015 9:36:26 AM
Teva (TEVA) Completes Acquisition Of Auspex Pharmaceuticals (ASPX) 5/5/2015 8:47:30 AM
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/30/2015 7:29:09 AM
Teva (TEVA) Reinforces Leadership Position In CNS With Acquisition Of Auspex Pharmaceuticals (ASPX) 3/30/2015 6:19:04 AM
Results Of Auspex Pharmaceuticals (ASPX)' Phase 3 Registration Trial Of SD-809 To Be Presented At American Academy of Neurology Annual Meeting 3/27/2015 6:09:54 AM
Auspex Pharmaceuticals (ASPX) Reports Fourth Quarter 2014 Results And Business Highlights 3/17/2015 7:34:09 AM
Auspex Pharmaceuticals (ASPX) To Present At The Cowen and Company Healthcare Conference 2/23/2015 7:37:34 AM
Auspex Pharmaceuticals (ASPX) Completes Enrollment In A Pivotal Clinical Trial Of SD-809 In Tardive Dyskinesia 2/3/2015 9:16:39 AM
Auspex Pharmaceuticals (ASPX) To Present At The 2015 Leerink Global Healthcare Conference 2/3/2015 7:52:32 AM
Auspex Pharmaceuticals (ASPX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/29/2015 7:42:55 AM